LK21-01g
Utility of pre-transplant flow cytometry tests of measurable residual disease in AML in first remission: CIBMTR analysis
Study #: LK21-01g
Study Status: Submitted
Utility of pre-transplant flow cytometry tests of measurable residual disease in AML in first remission: CIBMTR analysis
Study #: LK21-01g
Study Status: Submitted